EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›CETX

CETX

CEMTREX INC

Next earnings Aug 12, 2026

Avoid
$3.02
▼ -6.79%
$3.02▼ -98.01%
over 1Y
L $3.02EODHDH $202.50
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-6.8%
1W-21.1%
1M-66.4%
3M-45.1%
YTD-89.0%
1Y-98.0%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
D
Valuation
Overvalued
Filings
Flagged
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy

Revenue grew 14.4% YoY; but unprofitable (net margin -36.8%).

Revenue (FY2025) $76.5M · FY2025

The read

Weak on both the fundamentals and the price — little to like at the current level.

CEMTREX INC shows $76.5M in FY2025 revenue (+14.4% YoY), a -36.8% net margin, and -596.8% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$43.1M$45.0M$59.4M$66.9M$76.5M
Gross profit$17.0M$16.6M$25.7M$27.5M$32.3M
Operating income-$8.74M-$14.1M-$1.51M-$5.27M$510K
Net income-$7.81M-$13.0M-$9.20M-$7.23M-$28.1M
Diluted EPS$0.02————
Net margin-18.1%-28.9%-15.5%-10.8%-36.8%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$29.4M
EV / EBITDA15.8
EV / Sales0.4
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-134.7%
FCF yield-8.5%

Quality & risk

ROIC (est.)2.2%
Free cash flow-$1.77M
Total debt$13.5M
Net cash-$8.54M
Altman Z-Score-0.83 distress
Piotroski F-Score5/9

Capital returns

Buyback yield—
Dividend yield (est.)2.5%
Shareholder yield2.5%
Shares Δ YoY+300.9%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — restated periodic report (2026-01-16). Worth a closer look.
  1. 8-K Material event2026-06-02
  2. 8-K Shareholder vote2026-05-15
  3. 10-Q Quarterly report2026-05-15
  4. DEF 14A Proxy statement2026-03-26
  5. 8-K/A Amended 8-K2026-03-24
  6. 8-K Unregistered share sales2026-03-19
  7. 10-Q Quarterly report2026-02-17
  8. 8-K Acquisition / disposition2026-02-11
  9. 10-K/A Restated periodic report2026-01-16

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-022026-06-02open ↗10-QPeriod ending 2026-03-312026-05-15open ↗8-KPeriod ending 2026-05-152026-05-15open ↗DEF 14APeriod ending 2026-03-262026-03-26open ↗8-K/APeriod ending 2026-01-082026-03-24open ↗8-KPeriod ending 2026-03-182026-03-19open ↗DEF 14CPeriod ending 2026-03-162026-03-16open ↗PRE 14CPeriod ending 2026-03-062026-03-06open ↗10-QPeriod ending 2025-12-312026-02-17open ↗SCHEDULE 13G/AFiling2026-02-13open ↗8-KPeriod ending 2026-02-052026-02-11open ↗10-K/APeriod ending 2025-09-302026-01-16open ↗

Quality score

D
ValueGrowthProfitHealthMom.
ValueC
GrowthD
ProfitabilityF
Financial healthD
Momentum—
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✗Liabilities below 2× equity
  • ✗P/E below 25

Fair value est.

$0.13

Overvalued -96% vs price

cheapfair valueexpensive

Modified Graham: EPS $0.02 × (8.5 + 1.5 × 0.0% growth) × 0.77 quality = 6.5× multiple. An estimate, not a price target.

Revenue
$76.5M
+14.4% YoY
Net margin
-36.8%
ROE
-596.8%
P/E
151.0

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$76.5M+14.4%
Net income-$28.1M-288.9%
Gross profit$32.3M+17.5%
Operating income$510K+109.7%
Diluted EPS$0.02+102.0%
Cash & equivalents$4.97M+27.6%
Total assets$47.8M+8.3%
Total liabilities$39.1M-0.2%
Stockholders' equity$4.71M+0.0%
Gross: 42.2%Op.: 0.7%L/E: 8.29x

Frequently asked

Is CEMTREX INC (CETX) a buy?
CETX currently carries a Avoid rating with 3/5 conviction, derived from its latest SEC filings. Revenue grew 14.4% YoY; but unprofitable (net margin -36.8%).
What is CETX's fair value?
A Modified-Graham model based on CETX's SEC fundamentals estimates a fair value of about $0.13. It is an estimate from reported earnings, not a price target.
Is CETX overvalued or undervalued?
Against a Modified-Graham fair-value estimate, CETX currently appears overvalued relative to its SEC-grounded earnings power.
What is CEMTREX INC's quality score?
CETX scores 43.98039215686274/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001435064, latest 10-Q filed 2026-05-15) · EODHD · as of 6/26/2026, 8:11:38 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2023-08-30
GOVIL SAAGAR
CEO
Buy15.1K @ $0.95$14.4K
2023-08-25
GOVIL SAAGAR
CFO
Buy7.10K @ $0.91$6.46K
2023-08-24
GOVIL SAAGAR
CFO
Buy3.00K @ $0.93$2.79K
2023-06-15
GOVIL SAAGAR
CFO
Buy27.8K @ $0.97$26.8K
2023-06-14
GOVIL SAAGAR
CEO
Buy8.03K @ $0.93$7.48K
2023-06-13
GOVIL SAAGAR
CEO
Buy45.7K @ $0.84$38.1K
2023-06-12
GOVIL SAAGAR
CEO
Buy10.7K @ $0.71$7.56K
2023-06-12
GOVIL SAAGAR
CEO
Buy1.00K @ $9.85$9.85K
2023-03-02
GOVIL SAAGAR
CEO
Buy1.00K @ $8.09$8.09K
2023-03-02
GOVIL SAAGAR
CEO
Buy5.00K @ $0.69$3.45K
2018-08-30
GOVIL SAAGAR
Chairman, CEO and President
Buy2.00K @ $4.24$8.48K
2018-08-22
GOVIL SAAGAR
Chairman, CEO and President
Buy12.0K @ $1.68$20.2K

Dividends

Irregular
Yield (TTM)
—
Annual / share
—
Last ex-date
2017-03-29
Last amount
$100,000.00
ex 2017-03-29paid 2017-04-19$100,000.00

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Recent news

market news →
Cemtrex Reports Fiscal Year 2026 Second Quarter Financial ResultsBullish
globenewswire.com· 2026-05-15
Cemtrex Stock Surges Higher on U.S. Navy Contract. Should You Chase the Rally?Bullish
finance.yahoo.com· 2026-04-07
US judge orders former Cemtrex exec to pay back ill-gotten gainsBearish
finance.yahoo.com· 2026-01-20
Cemtrex, Inc. Announces $4 Million Registered Direct OfferingBullish
globenewswire.com· 2026-01-09
Cemtrex Completes Acquisition of Invocon, Launches Aerospace & Defense Segment and Expands Participation in Missile Defense ModernizationBullish
globenewswire.com· 2026-01-08
BC-Most Active StocksBullish
finance.yahoo.com· 2025-12-30

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score44 vs 67
Revenue growth14.4% vs 7.1%
Net margin-36.8% vs 10.5%
Return on equity-596.8% vs 12.3%
P/E151.0 vs 25.5